FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to field of medicine, to disinfectants. Disinfectant is secondary (poly)N,N-diallylammonium trifluoroacetate (PDAATFA) and tertiary (poly)N,N-diallyl-N-methylammonium trifluoroacetate (PDAMATFA), obtained on the basis of trifluoroacetates of diallylamines (DAA) (DAA monomer itself and N,N-diallyl-N-Nmethylamine (DAMA)), polydiallylammonium salts of general formula: 
where R=H; R=CH3; n=114-244 (average-weight degree of polymerization); Mw=24000-55000 g/mol (average-weight molecular weight); δ=1.85 is coefficient of polydispersibility of molecular-weight distribution Mw-Mn, where Mn is average-number molecular weight, as mycobactericidal and tuberculocidal disinfectant.
EFFECT: invention ensures bacteria death within 15-30 minutes and possesses in vitro mycobactericidal and tuberculocidal activity.
3 tbl, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETERMINATION OF EFFICIENCY OF DISINFECTANTS USED IN TB FACILITIES | 2008 |
|
RU2364629C1 |
| USE OF AN ANTISEPTIC AND DISINFECTANT AGENT | 2022 |
|
RU2801796C1 |
| POLYDIALLYLAMINES AND DISINFECTING AGENT COMPRISING THEREOF | 2004 |
|
RU2272045C1 |
| PHARMACEUTICAL COMPOSITION FOR PROPHYLAXIS AND ADDITIONAL CHEMOTHERAPY OF TUBERCULOSIS | 2004 |
|
RU2295330C2 |
| ANTITUBERCULOUS THERAPEUTIC AGENT: COMPOSITION OF IMIDAZO[1,2-b]TETRAZINE AND PYRAZINAMIDE | 2013 |
|
RU2545458C2 |
| ANTI-TUBERCULOSIS DRUG BASED ON (Z)-3-(3,3-DIMETHYL-2-OXOBUTYLIDENE) -3,4-DIHYDRO-2H-1,4-BENZOXAZIN-2-ONE AND A METHOD FOR ITS SYNTHESIS | 2020 |
|
RU2748748C1 |
| FURILIDENE FURANONE DERIVATIVES OF USNIC ACID AS NEW ANTITUBERCULOSIS AGENTS | 2013 |
|
RU2533707C1 |
| AMINOTHIAZOLE DERIVATIVES OF USNIC ACID AS NOVEL ANTI-TUBERCULOSIS AGENTS | 2012 |
|
RU2483722C1 |
| QUATERNARY AMMONIUM DERIVATIVES OF 2-AMINOTHIOPHEN-3-CARBOXYLATES HAVING ANTI-TUBERCULOSIS ACTIVITY | 2016 |
|
RU2629369C1 |
| SELECTIVE INHIBITORS OF GLYCERALDEHYDE-3-PHOSPHATEDEHYDROGENASE OF MICROBACTERIA | 2017 |
|
RU2661151C1 |
